Travis Yates

Company: Personalis Inc

Job title: Field Applications Scientist

Seminars:

Personalis NeXT Platform: Precision Neoantigen Selection & MRD Detection 2:30 pm

The Personalis NeXT Platform integrates deep tumor tissue profiling with ultrasensitive plasma-based monitoring to support neoantigen-based immunotherapy development. • ImmunoID NeXT delivers comprehensive immunogenomic profiling from tumor tissue, enabling accurate neoantigen selection through validated exome/transcriptome assays, and neoantigen predictions trained on immunopeptidomics data • NeXT Personal is a tumor-informed, plasma-based assay for detecting molecular residual…Read more

day: Conference Day One